Subject(s)
Microscopy, Confocal , Humans , Microscopy, Confocal/methods , Male , Epithelium, Corneal/pathology , Recovery of Function , Female , AdultABSTRACT
Endothelial dysfunction is a leading cause of corneal blindness in developed countries and the only available treatment is the endothelial transplantation. However, the limited availability of suitable donors remains a significant challenge, driving the exploration of alternative regenerative therapies. Advanced Therapy Medicinal Products show promise but must adhere to strict regulations that prohibit the use of animal-derived substances. This study investigates a novel culture methodology using Plasma Rich in Growth Factors (PRGF) as the only source of growth factors for primary cultures of human corneal endothelial cells (CECs). CECs were obtained from discarded corneas or endothelial rings and cultured in two different media: one supplemented with xenogeneic factors and other xenogeneic-free, using PRGF. Comprehensive characterization through immunofluorescence, morphological analyses, trans-endothelial electrical resistance measurements, RNA-seq, and qPCR was conducted on the two groups. Results demonstrate that CECs cultured in the xenogeneic-free medium exhibit comparable gene expression, morphology, and functionality to those cultured in the xenogeneic medium. Notably, PRGF-expanded CECs share 46.9% of the gene expression profile with native endothelium and express all studied endothelial markers. In conclusion, PRGF provides an effective source of xenogeneic-free growth factors for the culture of CECs from discarded corneal tissue. Further studies will be necessary to demonstrate the applicability of these cultures to cell therapies that make clinical translation possible.
Subject(s)
Endothelial Cells , Endothelium, Corneal , Animals , Humans , Endothelial Cells/metabolism , Cornea/metabolism , Cell- and Tissue-Based Therapy , Cells, CulturedABSTRACT
El desprendimiento de la membrana de Descemet es una complicación potencial tras la queratoplastia endotelial de la membrana de Descemet (DMEK, acrónimo en inglés de Descemet membrane endothelial keratoplasty). En este artículo presentamos un caso clínico de una cirugía DMEK en un caso complicado, que presentó un desprendimiento casi completo del injerto y posteriormente una opacificación de este y la formación de una seudocámara anterior. En noviembre del 2020, se realizó una cirugía DMEK a un paciente de 64 años debido a una descompensación endotelial. Tres meses después del DMEK, se observó el injerto desprendido y parcialmente adherido, fibrótico en la cámara anterior y formando una seudocámara anterior. Sin embargo, la córnea se mantuvo totalmente transparente con un recuento endotelial de aproximadamente 1.204 células/mm2 y la agudeza visual con corrección fue 20/25. Tres meses más tarde, se objetivó una opacificación significativa del injerto despegado y la agudeza visual disminuyó a 20/63. Procedimos a la extracción del injerto sin realizar una segunda DMEK. Diez meses más tarde, la córnea permaneció transparente con un recuento endotelial de 510 células/mm2 y la agudeza visual con corrección fue 20/25 (AU)
Descemet Membrane detachment is a potential complication after Descemet Membrane Endothelial Keratoplasty (DMEK). Here, we present a unique case of a DMEK surgery in a complicated eye that suffered a nearly complete DMEK graft detachment and later a graft opacification with a pseudo-anterior chamber. In Mid-November 2020, a planned DMEK was performed in a 64-year-old male patient due to corneal decompensation. Four months after DMEK, a fibrotic DMEK graft was seen across the anterior chamber with a pseudo-anterior chamber; however, the recipient cornea showed complete clearance with an endothelial cell count of about 1204 cells/mm2 and a best-corrected visual acuity of 20/25. Three months later, we observed a significant opacification of the detached graft, and the best-corrected distance visual acuity decreased to 20/63. We proceeded with the graft removal without performing a second DMEK. Ten months after graft removal, the cornea remained clear with an endothelial cell count of about 510 cells/mm2, and the best-corrected visual acuity was 20/25 (AU)
Subject(s)
Humans , Male , Middle Aged , Corneal Diseases/surgery , Descemet Stripping Endothelial Keratoplasty , Endothelium, Corneal/surgery , Transplantation, Autologous , Visual Acuity , Slit Lamp , Tomography, Optical Coherence , Corneal Diseases/diagnostic imagingABSTRACT
Descemet Membrane detachment is a potential complication after Descemet Membrane Endothelial Keratoplasty (DMEK). Here, we present a unique case of a DMEK surgery in a complicated eye that suffered a nearly complete DMEK graft detachment and later a graft opacification with a pseudo-anterior chamber. In Mid-November 2020, a planned DMEK was performed in a 64-year-old male patient due to corneal decompensation. Four months after DMEK, a fibrotic DMEK graft was seen across the anterior chamber with a pseudo-anterior chamber; however, the recipient cornea showed complete clearance with an endothelial cell count of about 1204 cells/mm2 and a best-corrected visual acuity of 20/25. Three months later, we observed a significant opacification of the detached graft, and the best-corrected distance visual acuity decreased to 20/63. We proceeded with the graft removal without performing a second DMEK. Ten months after graft removal, the cornea remained clear with an endothelial cell count of about 510 cells/mm2, and the best-corrected visual acuity was 20/25.
Subject(s)
Corneal Diseases , Descemet Stripping Endothelial Keratoplasty , Male , Humans , Middle Aged , Endothelium, Corneal , Visual Acuity , Cornea , Corneal Diseases/surgeryABSTRACT
Objetivos Analizar la situación actual de la cirugía refractiva con implante de lente fáquica Visian ICL en España, señalando los rangos medios de potencias implantadas, los resultados visuales y refractivos obtenidos y los índices de seguridad y eficacia. Método Se trata de un estudio de población, transversal, descriptivo, analítico, retrospectivo, multicéntrico, en el que cada coautor recopiló los datos de, al menos, los 10 últimos pacientes (hasta un máximo de 30) con implante de lente fáquica Visian ICL. Se eligió aleatoriamente un ojo de cada sujeto para incluirlo en el estudio, y se analizaron las variables: edad, género, agudezas visuales sin corrección y con corrección pre y posquirúrgica, refracción preoperatoria y residual, queratometrías, recuento endotelial, profundidad de cámara anterior desde endotelio, paquimetría corneal central, presión intraocular, distancia blanco-blanco, lente implantada (potencia y talla) y equivalente esférico (SEQ) esperado y obtenido posquirúrgico al mes de la cirugía. Resultados Se obtuvo una muestra de 140 ojos de 140 pacientes con una edad media de 31,35±7,28 años. El SEQ preoperatorio medio fue de −6,33±3,69, la agudeza visual con corrección media de 0,96±0,16, la profundidad de cámara anterior desde endotelio de 3,30±0,29mm, distancia blanco-blanco 12,02±0,40mm, paquimetría corneal central 535,03±37,68μm, recuento endotelial 2.684,37±313,74céls/mm2 y presión intraocular 14,84±2,59mmHg. El 66,4% de las lentes implantadas fueron ICL esféricas y el 33,6% tóricas, con una potencia media de −7,81±4,09D y un cilindro medio de 2,27±1,23D. El 5,7% fueron hipermetrópicas. El 45,69% de las lentes implantadas eran de la talla 13,2mm, siendo el 37,93, 12,93 y 3,45% restante de las tallas 12,6, 12,1 y 13,7mm, respectivamente. Al mes de la cirugía se obtuvo un SEQ residual de −0,01±0,31D. Los índices de eficacia y seguridad fueron de 1,06±0,18 y 1,10±0,19, respectivamente... (AU)
Objectives To analyse the state of refractive surgery with Visian ICL phakic lens implantation in Spain, indicating the mean ranges of implanted powers, visual and refractive outcomes obtained and safety and efficacy indices. Method This is a population-based, cross-sectional, descriptive, analytical, retrospective, multicentre study in which each co-author collected data from at least the last 10 patients (up to a maximum of 30) with Visian ICL phakic lens implantation. One eye from each subject was randomly selected for study inclusion, and the variables analysed were: age, gender, visual acuities with and without correction pre and post-surgery, preoperative and residual refraction, keratometry, endothelial cellular density, anterior chamber depth from endothelium, central corneal pachymetry, intraocular pressure, white-white, implanted lens (power and size), expected and achieved spherical equivalent (SEQ) post-surgery at one month after surgery. Results A sample of 140 eyes was obtained from 140 patients with a mean age of 31.35±7.28 years. Mean preoperative SEQ was −6.33±3.69D, mean visual acuities with correction was 0.96±0.16, anterior chamber depth was 3.30±0.29mm, white-white 12.02±0.40mm, central corneal pachymetry 535.03±37.68μm, endothelial cellular density 2684.37±313.74cels/mm2 and intraocular pressure 14.84±2.59mmHg. A percentage of 66.4 of the implanted lenses were spherical ICLs and 33.6% toric, with a mean power of −7.81±4.09D and a mean cylinder of 2.27±1.23D. A percentage of 5.7 of the implanted lenses were hypermetropic. The mean SEQ target selected was +0.04±0.27D. A percentage of 45.69 of the implanted lenses were of size 13.2mm, with the remaining 37.93, 12.93 and 3.45% being of sizes 12.6, 12.1 and 13.7mm, respectively. At one month after surgery a residual SEQ of −0.01±0.31D was obtained. The efficacy and safety indices were 1.06±0.18 and 1.10±0.19...(AU)
Subject(s)
Humans , Male , Female , Young Adult , Adult , Middle Aged , Refractive Surgical Procedures , Phakic Intraocular Lenses , Myopia/surgery , Cross-Sectional Studies , Retrospective Studies , Safety , EfficacyABSTRACT
OBJECTIVES: To analyse the state of refractive surgery with Visian ICL phakic lens implantation in Spain, indicating the mean ranges of implanted powers, visual and refractive outcomes obtained and safety and efficacy indices. METHOD: This is a population-based, cross-sectional, descriptive, analytical, retrospective, multicentre study in which each co-author collected data from at least the last 10 patients (up to a maximum of 30) with Visian ICL phakic lens implantation. One eye from each subject was randomly selected for study inclusion, and the variables analysed were: age, gender, visual acuities with and without correction pre and post-surgery, preoperative and residualrefraction, keratometry, endothelial cellular density, anterior chamber depth from endothelium, central corneal pachymetry, intraocular pressure, white-white, implanted lens (power and size), expected and achieved spherical equivalent (SEQ) post-surgery at one month after surgery. RESULTS: A sample of 140 eyes was obtained from 140 patients with a mean age of 31.35 ± 7.28 years. Mean preoperative SEQ was -6.33 ± 3.69D, mean CDVA was 0.96 ± 0.16, ACD was 3.30 ± 0.29 mm, WTW 12.02 ± 0.40 mm, CCT 535.03 ± 37.68 µm, ECD 2684.37 ± 313.74 cels/mm2 and IOP 14.84 ± 2.59 mmHg. 66.4% of the implanted lenses were spherical ICLs and 33.6% toric, with a mean power of -7.81 ± 4.09D and a mean cylinder of 2.27 ± 1.23D. 5.7% of the implanted lenses were hypermetropic. The mean SEQ target selected was +0.04 ± 0.27D. 48.92% of the implanted lenses were of size 13.2 mm, with the remaining 36.69, 10.79 and 3.60% being of sizes 12.6, 12.1 and 13.7 mm, respectively. At one month after surgery a residual SEQ of -0.01 ± 0.31D was obtained. The efficacy and safety indices were 1.06 ± 0.18 and 1.10 ± 0.19, respectively. The mean central vault was 508.80 ± 201.04 µm. The accuracy between the calculated SEQ and the obtained SEQ was 99.3% for spherical lenses and 88.2% for Cyl correction. The mean ECD at 1 month after surgery was 2805.53±273.30céls/mm2, which was a difference from preoperative of 0.11% (p = 0.922), similarly, the mean IOP was 13.98 ± 2.57 mmHg, which was a difference of -0.92 ± 2.80 mmHg. CONCLUSIONS: ICL phakic lens surgery is an effective, safe and predictable procedure. There were no significant changes in endothelial cell count or intraocular pressure measurement one month after surgery.
Subject(s)
Myopia , Phakic Intraocular Lenses , Humans , Young Adult , Adult , Retrospective Studies , Spain , Cross-Sectional Studies , Myopia/surgery , Lens Implantation, IntraocularABSTRACT
INTRODUCTION: Minor strokes are considered to be those that present with few symptoms, although up to 40% of them entail long-term disability. The rate of thrombolysis in these patients is also lower than in other strokes. The aim of this study is to explore whether there are any differences in intravenous thrombolysis care times in minor strokes. PATIENTS AND METHODS: We conducted a retrospective review of strokes treated with intravenous thrombolysis at our centre and a comparative analysis of the care times in minor strokes and in the other types. RESULTS: Longer times were found in minor strokes in terms of door-to-CT scan and door-to-needle time. This was not the case, however, for the time from the onset of symptoms to arrival at the hospital. CONCLUSIONS: The presence of few symptoms in minor strokes can make them difficult to recognise and could be a reason for delaying treatment. Training among staff caring for these patients is essential to improve this aspect.
TITLE: Retraso en la administración de tratamiento trombolítico en el ictus minor.Introducción. Se considera ictus minor a aquel que se presenta con escasos síntomas; sin embargo, hasta un 40% presenta discapacidad a largo plazo. La tasa de trombólisis en estos pacientes también es inferior a la del resto de ictus. En este estudio se pretende explorar si existen diferencias en los tiempos de atención en la trombólisis intravenosa en los pacientes con ictus minor. Material y métodos. Revisión retrospectiva de los ictus tratados con trombólisis intravenosa en nuestro centro y análisis comparativo de los tiempos de asistencia entre ictus minor y el resto. Resultados. Se encontraron tiempos más alargados en los casos de ictus minor en cuanto al tiempo puerta-tomografía computarizada y puerta-aguja. No fue así, sin embargo, para el tiempo desde el inicio de los síntomas hasta la llegada al hospital. Conclusiones. La presencia de escasos síntomas en el ictus minor puede hacer difícil su reconocimiento y podría ser un motivo de retraso en el tratamiento. La formación entre el personal que atiende a estos pacientes es fundamental para mejorar este aspecto.
Subject(s)
Fibrinolytic Agents/administration & dosage , Stroke/drug therapy , Thrombolytic Therapy , Time-to-Treatment , Administration, Intravenous , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness IndexABSTRACT
Introducción: Se considera ictus minor a aquel que se presenta con escasos síntomas; sin embargo, hasta un 40% presenta discapacidad a largo plazo. La tasa de trombólisis en estos pacientes también es inferior a la del resto de ictus. En este estudio se pretende explorar si existen diferencias en los tiempos de atención en la trombólisis intravenosa en los pacientes con ictus minor. Material y métodos. Revisión retrospectiva de los ictus tratados con trombólisis intravenosa en nuestro centro y análisis comparativo de los tiempos de asistencia entre ictus minor y el resto. Resultados: Se encontraron tiempos más alargados en los casos de ictus minor en cuanto al tiempo puerta-tomografía computarizada y puerta-aguja. No fue así, sin embargo, para el tiempo desde el inicio de los síntomas hasta la llegada al hospital. Conclusiones: La presencia de escasos síntomas en el ictus minor puede hacer difícil su reconocimiento y podría ser un motivo de retraso en el tratamiento. La formación entre el personal que atiende a estos pacientes es fundamental para mejorar este aspecto.(AU)
Introduction: Minor strokes are considered to be those that present with few symptoms, although up to 40% of them entail long-term disability. The rate of thrombolysis in these patients is also lower than in other strokes. The aim of this study is to explore whether there are any differences in intravenous thrombolysis care times in minor strokes. Patients and methods: We conducted a retrospective review of strokes treated with intravenous thrombolysis at our centre and a comparative analysis of the care times in minor strokes and in the other types. Results: Longer times were found in minor strokes in terms of door-to-CT scan and door-to-needle time. This was not the case, however, for the time from the onset of symptoms to arrival at the hospital. Conclusions: The presence of few symptoms in minor strokes can make them difficult to recognise and could be a reason for delaying treatment. Training among staff caring for these patients is essential to improve this aspect.(AU)
Subject(s)
Humans , Male , Female , Stroke/drug therapy , Thrombolytic Therapy/methods , Administration, Intravenous , Time-to-Treatment , Neurology , Nervous System Diseases , Retrospective Studies , Epidemiology, DescriptiveABSTRACT
PURPOSE: To assess the long-term outcomes of implanting intrastromal corneal ring segments (ICRSs) to correct central keratoconus with a high corneal asphericity value. METHODS: Forty-three eyes with central keratoconus with a corneal asphericity value ≥-1.00 were evaluated before and after implanting an inferior 210-degree arc-length Ferrara-type AFR5 ICRS (AJL Ophthalmic, Spain). Logarithm of the minimum angle of resolution uncorrected (UDVA) and best-corrected (CDVA) distance visual acuity, corneal asphericity, root mean square for coma-like aberrations [computed for the Zernike terms Z (3, 1) and Z (3, -1)], and residual refractive errors analyzed using vector analysis were recorded before and at all follow-up visits. The postoperative follow-up duration was 3 years in all cases. RESULTS: Mean UDVA (logarithm of the minimum angle of resolution scale) rose from 1.18 ± 0.59 to a postoperative 0.53 ± 0.39 after ICRS implantation (P < 0.0001). Mean CDVA varied in turn from 0.36 ± 0.18 to 0.17 ± 0.10 (P < 0.0001). CDVA remained unchanged or improved in all eyes after surgery. Both UDVA and CDVA were stable over the postoperative period (P > 0.05). The spherical equivalent declined steeply after ICRS implantation (P < 0.0001). Both spherical equivalent and refractive cylinder were stable over the postoperative period. The corneal asphericity and root mean square values for coma-like aberrations exhibited statistically significant decreases 6 months after ICRS implantation (P < 0.0001) and were also stable over postoperative follow-up (P > 0.05). CONCLUSIONS: These results suggest that implanting a single, inferior, 210-degree arc-length Ferrara-type ICRS is a safe, effective, and stable procedure for treating patients with central hyperprolate keratoconus.
Subject(s)
Cornea/pathology , Corneal Stroma/surgery , Keratoconus/surgery , Prostheses and Implants , Prosthesis Implantation , Adult , Corneal Pachymetry , Corneal Topography , Female , Follow-Up Studies , Humans , Keratoconus/pathology , Male , Middle Aged , Refraction, Ocular/physiology , Visual Acuity/physiology , Young AdultABSTRACT
Keratoconus provides a decrease of quality of life to the patients who suffer from it. The treatment used as well as the method to correct the refractive error of these patients may influence on the impact of the disease on their quality of life. The purpose of this review is to describe the evidence about the conservative surgical treatment for keratoconus aiming to therapeutic and refractive effect. The visual rehabilitation for keratoconic corneas requires addressing three concerns: halting the ectatic process, improving corneal shape, and minimizing the residual refractive error. Cross-linking can halt the disease progression, intrastromal corneal ring segments can improve the corneal shape and hence the visual quality and reduce the refractive error, PRK can correct mild-moderate refractive error, and intraocular lenses can correct from low to high refractive error associated with keratoconus. Any of these surgical options can be performed alone or combined with the other techniques depending on what the case requires. Although it could be considered that the surgical option for the refracto-therapeutic treatment of the keratoconus is a reality, controlled, randomized studies with larger cohorts and longer follow-up periods are needed to determine which refractive procedure and/or sequence are most suitable for each case.
ABSTRACT
Objetivo: Estudiar la correlación entre el error refractivo miópico y determinados rasgos de personalidad. Igualmente, se pretende determinar si existe correlación entre el grado de miopía y una mayor frecuencia de trastornos de la personalidad. Métodos: Estudio transversal observacional multicéntrico. La muestra la formaron 82 sujetos (26 hombres, 56 mujeres) mayores de 18 años con miopía (defecto esférico ≤ −0,5 D); 30 eran miopes magnos (<−6 D). Datos recogidos: edad y sexo, nivel de formación, resultado en el inventario de personalidad Neo PI-R, autorrefractometría, enfermedad miópica, tratamiento oftalmológico. Resultados: No se encontró correlación (rho de Spearman) estadísticamente significativa entre el defecto esférico y los rasgos de personalidad estudiados en el total de la muestra: neuroticismo (−0,057; p = 0,610), extraversión (−0,020; p = 0,857), apertura (−0,032; p = 0,774), amabilidad (−0,060; p = 0,592), responsabilidad (−0,034; p = 0,765). Al agruparlos por subgrupos de alta y baja significación (t-test), se halló una tendencia al aumento del defecto miópico con la extraversión, que resultó significativa (p = 0,002). Al comparar miopes magnos y el resto, se vio que existían diferencias significativas entre ambos grupos en cuanto a la enfermedad asociada (p < 0,001), el tratamiento recibido (p < 0,001) y el nivel de estudios ((p = 0,013), no así en las variables de personalidad: neuroticismo (p = 0,852), extraversión (p = 0,199), apertura (p = 0,560), amabilidad (p = 0,584), responsabilidad (p = 0,722). Conclusiones: Se encontró baja correlación entre miopía y personalidad. El grado de miopía no resultó diferente entre los grupos con diversos niveles de estudios. Los sujetos con enfermedad oftalmológica más grave asociada a la miopía presentaban puntuaciones más altas en neuroticismo, sin asociación significativa
OBJECTIVE: To study the correlation between the myopic refractive error and certain personality traits, and to determine whether there is a correlation between the degree of myopia and an increased frequency in personality disorders. METHODS: Cross-sectional observational multicenter study conducted on 82 subjects (26 men, 56 women) age over 18 years with myopia (spherical defect ≤ −0.5 D), with 30 subjects having high myopia (<−6 D). Data collected: age and gender, academic level, result in the Neo PI-R personality test, autorefractometry, myopic pathology, and ophthalmological treatment. RESULTS: Correlation (Spearman's) between the magnitude of the spherical defect and the 5 personality traits studied in the total sample was not statistically significant: neuroticism (−0.057; P=.610), extroversion (−0.020; P=.857), openness (−0.032; P=.774), kindness (−0.060; P=.592), and responsibility (−0.034;P=.765). By dividing them into subgroups of low and high significance (t-test), a significant (P=.002) upward trend of the myopic defect with increasing scores on extraversion was found. When comparing high myopic subjects to the non-high myopic ones, there were significant differences between the 2 groups in terms of the associated pathology (P=.001), received treatment (P=.001) and the level of studies (P=.013). There were no differences in the variables of personality: neuroticism (P=.852), extroversion (P=.199), openness (P=.560), kindness (P=.584), and responsibility (P=.722). CONCLUSIONS: A low correlation was found between myopia and personality. There was no difference in the degree of myopia between the groups with different education levels. Subjects with more severe ocular pathology associated with myopia had higher scores in neuroticism, without finding any significant association
Subject(s)
Adult , Female , Humans , Male , Myopia/psychology , Personality Disorders/complications , Personality Disorders/diagnosis , Personality Disorders/psychology , Extraversion, Psychological , Cross-Sectional Studies/methods , Cross-Sectional Studies/trends , Personality Inventory/statistics & numerical data , Personality Inventory/standards , Informed Consent/standardsABSTRACT
OBJECTIVE: To study the correlation between the myopic refractive error and certain personality traits, and to determine whether there is a correlation between the degree of myopia and an increased frequency in personality disorders. METHODS: Cross-sectional observational multicenter study conducted on 82 subjects (26 men, 56 women) age over 18 years with myopia (spherical defect ≤ -0.5 D), with 30 subjects having high myopia (<-6 D). DATA COLLECTED: age and gender, academic level, result in the Neo PI-R personality test, autorefractometry, myopic pathology, and ophthalmological treatment. RESULTS: Correlation (Spearman's) between the magnitude of the spherical defect and the 5 personality traits studied in the total sample was not statistically significant: neuroticism (-0.057; P=.610), extroversion (-0.020; P=.857), openness (-0.032; P=.774), kindness (-0.060; P=.592), and responsibility (-0.034; P=.765). By dividing them into subgroups of low and high significance (t-test), a significant (P=.002) upward trend of the myopic defect with increasing scores on extraversion was found. When comparing high myopic subjects to the non-high myopic ones, there were significant differences between the 2 groups in terms of the associated pathology (P=.001), received treatment (P=.001) and the level of studies (P=.013). There were no differences in the variables of personality: neuroticism (P=.852), extroversion (P=.199), openness (P=.560), kindness (P=.584), and responsibility (P=.722). CONCLUSIONS: A low correlation was found between myopia and personality. There was no difference in the degree of myopia between the groups with different education levels. Subjects with more severe ocular pathology associated with myopia had higher scores in neuroticism, without finding any significant association.
Subject(s)
Myopia/psychology , Personality , Adult , Aged , Comorbidity , Cross-Sectional Studies , Extraversion, Psychological , Female , Humans , Male , Middle Aged , Myopia/epidemiology , Personality Disorders/epidemiology , Personality Inventory , Young AdultABSTRACT
Objetivo: determinar la eficacia del agregado del zinc en la preparación de suero de hidratación oral versus administración clásica de hidratación y su efecto en el crecimiento, estado clínico nutricional e inmunitario de niños con diarrea aguda menores de 5 años. Métodos: estudio experimental aleatorizado realizado en el Hospital del Nin@ Manuel Ascencio Villarroel. De 700 niños con diarrea aguda 117 ingresaron al estudio previo consentimiento de padres: 31 conformaron el grupo estudio, 42 fueron controles (44 abandonaron); con criterios de inclusión, exclusión. El GTROCRIN (SRO+ZINC) recibió zinc 20mg/1000cc en la misma preparación del suero y el GSROH (SRO) solución hidratante oral hipo-osmolar aparte zinc 2mg/Kg. Se realizaron: Examen clínico, tomas de muestras para hemograma, orina, heces además de antropometría, cuantificación de aporte calórico, tolerancia oral, gasto fecal y respuesta inmunitaria por ecografía de timo repetidos a diez días. Los datos fueron procesados SPSS 19, p< 0,05; IC: 95%. Resultados: al ingreso ningún niño presentó deshi-dratación grave ni complicaciones severas, copro-parasitológicos fueron negativos 51,61% (16) GTROCRIN, 35,71 % (15) GSROH. AMEBAS: GTROCRIN: 32,25%(10); GSROH: 50%(21).GIARDIA: GTROCRIN: 12,90%(4); GSROH: 14,28%(6). AMBOS PARÁSITOS: GTROCRIN: 3,22% (1). Al concluir el estudio GTROCRIN: P/TZ, T/EZ, P/EZ, IMC/Z,MM,MG,SOM mejoraron (p<0,0001). Diarrea duró 4,16±1,55 (GTROCRIN) vs7, 80±1,1 días (GSROH). GTROCRIN recibió mayor aporte calórico (P<0,0001), tolero mejor, tuvo menor gasto fecal, la diarrea cedió 81,64% (25). (p<0,001), mejoró la superficie, espesor del timo 617,52±111; 24,44±3,85vs GSROH: 453,46±74,82; 19,80±1,61 (p<<0,001) en este grupo la evolución fue tórpida en 11,9% (5) niños. Conclusiones: el estudio muestra mayor eficacia en el tratamiento de la diarrea aguda con el agregado del zinc en suero de hidratación oral que sin el, en la mejoría clínico-nutricional e inmunitaria.
Objective: to determine the efficacy of the addition of zinc in the preparation of oral rehydration serum versus classical administration of hydration and its effect on growth, nutritional status and clinical immune children with acute diarrhea in children under 5 years. Methods: experimental randomized study of the Children's Hospital Manuel Ascencio Villarroel. From seven hundred children with acute diarrhea 117 were studied prior consent of parents. 31 formed the study group, 42 were controls (44 abandoned ). The GTROCRIN group (SRO + ZINC ) received zinc 20mg/1000cc in the same preparation of oral serum, and GSROH group (GSROH ) received oral hypo-osmolar hydrating solution with zinc 2mg/Kg apart. It were performed clinical examination, samples for blood count, urine, feces plus anthropometry, quantification of caloric intake, oral tolerance, fecal output and immune response of thymus repeated ultrasound to ten days. Data were processed SPSS 19, p < 0.05; IC: 95 %. Results: on admission no child had severe dehydration or severe complications were negative copro-parasitological 51.61 % (16) GTROCRIN, 35.71 % (15) GSROH. AMOEBAE: GTROCRIN: 32.25% (10); GSROH: 50 % (21). GIARDIA: GTROCRIN: 12.90% (4); GSROH: 14.28% (6 ) . BOTH PARASITES: GTROCRIN: 3.22 % (1). At the conclusion of the study GTROCRIN: P/T, T/EZ, P/EZ, IMC/ Z, MM, MG, SOM improved (p < 0.0001). Diarrhea lasted 4.16 ± 1.55 (GTROCRIN) vs. 7,80 ± 1.1 days ( GSROH ) . GTROCRIN received increased energy intake (P < 0.0001), I tolerate better, had less stool output, diarrhea yielded 81.64 % (25), (p < 0.001), improved surface thickness thymus 617.52 ± 111; 24.44 ± 3.85 vs. GSROH: 453.46 ± 74.82; 19.80 ± 1.61 (p < < 0.001) in this group evolution was torpid in 11.9 % (5) children. Conclusions: The study shows greater efficacy in the treatment of acute diarrhea with the addition of zinc in serum without oral hydration in clinical nutrition and immune improvement.
Subject(s)
ZincABSTRACT
CASO CLÍNICO: Mujer de 22 años, diagnosticada previamente de quiste de inclusión conjuntival en el sector nasal del ojo izquierdo y tratada mediante dos drenajes incisionales, que acude a nuestra consulta con hiposfagma universal acompañado de intenso dolor. Tras realizar una biopsia escisional, fue diagnosticada de hemangioma capilar conjuntival. DISCUSIÓN: El hemangioma capilar conjuntival es una lesión mayoritariamente benigna, asintomática y congénita, siendo rara pero posible su evolución o su aparición de novo en edades adultas
CLINICAL CASE: A 22-year-old woman patient, diagnosed with an inclusion cyst of the conjunctiva in the nasal sector of the left eye, who after 2 shot/needle injections in the lesion came to our clinic with a dense subconjunctival hemorrhage in four quadrants and with severe pain. After excision biopsy, a capillary hemangioma of the conjunctiva was diagnosed. DISCUSSION: Conjunctival capillary hemangioma is mainly a benign lesion, asymptomatic and mostly congenital in origin, its progression or de novo growth is rare in adulthood
Subject(s)
Humans , Female , Young Adult , Hemangioma, Capillary/diagnosis , Conjunctival Neoplasms/diagnosis , BiopsyABSTRACT
CLINICAL CASE: A 22-year-old woman patient, diagnosed with an inclusion cyst of the conjunctiva in the nasal sector of the left eye, who after 2 shot/needle injections in the lesion came to our clinic with a dense subconjunctival hemorrhage in four quadrants and with severe pain. After excision biopsy, a capillary hemangioma of the conjunctiva was diagnosed. DISCUSSION: Conjunctival capillary hemangioma is mainly a benign lesion, asymptomatic and mostly congenital in origin, its progression or de novo growth is rare in adulthood.
Subject(s)
Conjunctival Neoplasms/pathology , Hemangioma, Capillary/pathology , Age Factors , Conjunctival Neoplasms/etiology , Female , Hemangioma, Capillary/etiology , Humans , Young AdultABSTRACT
PURPOSE: To compare visual and refractive results of Toric Implantable Collamer Lens (TICL) and bioptics (ICL plus excimer corneal surgery) to treat myopic astigmatism. METHODS: Eighty-one eyes underwent TICL implantation and 83 eyes were treated with bioptics (corneal ablation was performed between 1.5 and 6 months after ICL implantation). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refraction, adverse events, safety, and efficacy were evaluated 12 months postoperatively. RESULTS: At 12 months postoperatively, the mean spherical equivalent was -0.15 ± 0.36 diopters (D) in the TICL group and -0.08 ± 0.26 D in the bioptics group (p = 0.099). Sixty-six (81.5 %) and 78 (94.0 %) eyes were within ±0.50 D for TICL and bioptics groups, respectively. The mean Snellen UDVA was not statistically different between both procedures (p = 0.909); 53 (65.4 %) and 54 (65.1 %) eyes achieved at least 20/25 or better in TICL and bioptics groups, respectively. No eye had lost more than two lines of CDVA, and 32.1 % of eyes (26/81) in the TICL group and 57.8 % of eyes (48/83) in the bioptics group had better postoperative UDVA than preoperative CDVA (p < 0.001). Safety was not statistically different between groups (p = 0.464) while efficacy was significantly higher in the bioptics group (p = 0.000). Two eyes with a TICL were treated to correct TICL decentration. CONCLUSIONS: Bioptics showed slightly better outcomes in some clinical measures such as uncorrected visual acuity, efficacy, and refractive predictability. TICL implantation shows reliable results similar to bioptics. A single procedure with TICL implantation might be preferred, eliminating the inherent risks of laser treatments and the risks of a second surgical procedure.
Subject(s)
Astigmatism/surgery , Lens Implantation, Intraocular , Myopia/surgery , Phakic Intraocular Lenses , Refraction, Ocular/physiology , Visual Acuity/physiology , Adult , Astigmatism/physiopathology , Female , Humans , Keratomileusis, Laser In Situ , Male , Middle Aged , Myopia/physiopathology , Optics and Photonics , Photorefractive Keratectomy , Treatment Outcome , Young AdultABSTRACT
It has been recently demonstrated that progranulin is overexpressed in ovarian cancer and that this protein is involved in the stimulation of cell proliferation, malignancy, and chemoresistance in ovarian cancer. The goal of the present study was to establish the differences in progranulin expression among normal, benign, and malignant ovarian tissues and to identify the signal transduction pathways activated by progranulin in an ovarian cancer cell line. Compared with benign tumors and normal ovarian tissue, progranulin mRNA and protein were overexpressed in malignant tumors. Survival analysis by the Kaplan-Meier method showed a correlation between high mRNA expression levels with poor survival outcome. Progranulin activated the MAPK-signaling pathway in NIH-OVCAR-3 cells. Progranulin expression may be potentially involved in the pathogenesis and malignant progression of ovarian cancer, and thus may represent a therapeutic target for this particular malignancy.
Subject(s)
Intercellular Signaling Peptides and Proteins/metabolism , Ovarian Neoplasms/metabolism , Ovary/metabolism , Adult , Aged , Aged, 80 and over , Apoptosis , Cell Line , Cell Line, Tumor , Cell Proliferation , Cell Survival , Female , Humans , Intercellular Signaling Peptides and Proteins/genetics , MAP Kinase Signaling System , Middle Aged , Ovarian Neoplasms/mortality , ProgranulinsABSTRACT
The development of the preimplantation mammalian embryo from a fertilized egg to a blastocyst capable of implanting in the uterus is a complex process. Cell division must be carefully programmed. The embryonic genome must be activated at the appropriate stage of development, and the pattern of gene expression must be carefully coordinated for the initiation of the correct program of differentiation. Cell fates must be chosen to establish specific cell types such as the inner cell mass and the trophectoderm, which give rise to the embryo proper and the placenta, respectively. This review summarizes recent findings concerning the influence of growth factors on the development of preimplantation mammalian embryos. Maternal factors secreted into the lumen of the female reproductive tract as well as substances synthesized by the developing embryo itself help to regulate this process. Studies of embryos in culture and investigations using homologous recombination to create embryos and animals null for specific genes have enabled the identification of several growth factors that appear essential for preimplantation mammalian embryo development. Some of the factors are required maternal factors; others are embryo-derived autocrine and paracrine factors. Studies using molecular biology are beginning to identify differences in the patterns of genes expressed by naturally derived embryos and those developing in culture. The knowledge gained from studies on growth factors, media, embryonic development, and gene expression should help improve culture conditions for embryos and will provide for safer outcomes from assisted reproductive procedures in human and animal clinics.
Subject(s)
Cleavage Stage, Ovum/physiology , Embryonic and Fetal Development/physiology , Gene Expression Regulation, Developmental/drug effects , Growth Substances/physiology , Animals , Cleavage Stage, Ovum/drug effects , Culture Media/pharmacology , Cytokines/physiology , Embryo Transfer , Embryonic and Fetal Development/drug effects , Female , Fertilization in Vitro , Forecasting , Growth Substances/classification , Growth Substances/pharmacology , Humans , Mammals/embryology , Mammals/physiology , Mice , Multigene Family , Pregnancy , Receptors, Cytokine/drug effects , Receptors, Cytokine/physiology , Receptors, Growth Factor/drug effects , Receptors, Growth Factor/physiologyABSTRACT
Spermatozoa are highly polarized cells with specific metabolic pathways compartmentalized in different regions. Previously, we hypothesized that glycolysis is organized in the fibrous sheath of the flagellum to provide ATP to dynein ATPases that generate motility and to protein kinases that regulate motility. Although a recent report suggested that glucose is not essential for murine sperm capacitation, we demonstrated that glucose (but not lactate or pyruvate) was necessary and sufficient to support the protein tyrosine phosphorylation events associated with capacitation. The effect of glucose on this signaling pathway was downstream of cAMP, and appeared to arise indirectly as a consequence of metabolism as opposed to a direct signaling effect. Moreover, the phosphorylation events were not affected by uncouplers of oxidative respiration, inhibitors of electron transfer, or by a lack of substrates for oxidative respiration in the medium. Further experiments aimed at identifying potential regulators of sperm glycolysis focused on a germ cell-specific isoform of hexokinase, HK1-SC, which localizes to the fibrous sheath. HK1-SC activity and biochemical localization did not change during sperm capacitation, suggesting that glycolysis in sperm is regulated either at the level of substrate availability or by downstream enzymes. These data support the hypothesis that ATP specifically produced by a compartmentalized glycolytic pathway in the principal piece of the flagellum, as opposed to ATP generated by mitochondria in the mid-piece, is strictly required for protein tyrosine phosphorylation events that take place during sperm capacitation. The relationship between these pathways suggests that spermatozoa offer a model system for the study of integration of compartmentalized metabolic and signaling pathways.
Subject(s)
Signal Transduction , Sperm Capacitation , Spermatozoa/metabolism , Adenosine Triphosphate/metabolism , Animals , Cell Differentiation , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Glucose/metabolism , Glycolysis , Hexokinase/chemistry , Immunoblotting , Kinetics , Lactic Acid/pharmacology , Male , Mice , Phosphorylation/drug effects , Protein Isoforms , Pyruvic Acid/pharmacology , Spectrophotometry , Sperm Capacitation/drug effects , Time Factors , Tyrosine/metabolismABSTRACT
This study is concerned with the influence of biological suspension on the position of the binodal curve in aqueous two-phase systems (ATPSs). Three different biological suspensions (i.e., disrupted yeast, E. coli homogenate and fermentation broth from Trichoderma harzianum) were selected and their impact upon ATPS performance was evaluated on the basis of changing volume ratio (Vr) and the position of the binodal curve of biological ATPSs (added with biomass). Biological ATPSs with initial Vr greater than 1 and long (>40%, w/w) tie-line length (TLL), exhibited significant changes in Vr when compared with that from non-biological systems. Such behaviour was associated with the top phase biomass accumulation. It was shown that the addition of the biological suspensions used in this study to ATPSs caused the binodal curve to displace towards the origin, which was associated with the critical contribution of the bio-polymer (present in the systems) to the phase formation. The practical implementation of ATPSs for the purification of biological materials exploiting the information reported in this study is discussed.